Fermeate
Enabling the next generation of biomanufacturing with light
San Francisco, United States · Founded 2024 · $2.0M raised
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2024
- Business Model
- B2B
- Website
- fermeate.com
- Total Funding
- $2.0M
- Last Round
- $2.0M SeedApr 2026
- Rounds
- 1
About
Fermeate is a San Francisco-based industrial biotechnology company founded in 2024 that applies optogenetics and photomolecular gene circuits to control microbial gene expression during fermentation. Its light-based platform retrofits existing stainless-steel bioreactors at under 5% of new-capacity costs, delivering 60–300% productivity improvements for food, ingredients, and biomanufacturing partners. Fermeate's $2M seed round was led by Newfund Capital with participation from SOSV, Ajinomoto Group Ventures, and others.
Summary
Fermeate is a Biotech company based in San Francisco, United States, founded in 2024. It has raised $2.0M in total across 1 round, most recently a $2.0M Seed round in Apr 2026.
Tech & App Stack
1 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Apr 2026
Similar Companies
Decarbonizing the chemicals industry.
Leading North American energy infrastructure platform.
Self-driving cars.
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...